Determinants of outcome and safety of intravenous rt-PA therapy in the very old: A clinical registry study and systematic review [3]

Age and Ageing

Volumn 37, Issue 1, 2008, Pages 107-111

  Meseguer, Elena ^a   Labreuche, Julien ^a   Olivot, Jeam Marc ^a   Abboud, Halim ^a   Lavallee, Philippa C ^a   Simon, Olivier ^a   Cabrejo, Lucie ^a   Echeverria, Amaya ^a   Klein, Isabelle F ^a,b   Mazighi, Mikael ^a   Amarenco, Pierre ^a  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; GLUCOSE;

AGE DISTRIBUTION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; GERIATRICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL; REGISTER; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; FEMALE; FIBRINOLYTIC AGENTS; FRANCE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; ODDS RATIO; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 38549106604     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afm177     Document Type: Letter

References (23)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
2. Agence Nationale d'Accréditation et d'Évaluation en Santé/Services de recommandations professionnelles. Prise en charge initiale des patients adultes atteints d'un accident cérébral aspects médicaux [monograph on the internet]. http://www.srlf.org/Data/Module Gestion De Contenu/application/623.pdf
3. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
4. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-51.
5. Clark WM, Wissman S, Albers GW et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-26.
6. Hacke W, Kaste M, Fieschi C et al. A placebo controlled trial of alteplase (rt-PA) in acute ischemic hemispheric stroke where thrombolysis is initiated between 3-and 4 hours after stroke onset [abstract on the internet]. In Ongoing Clinical Trials Session, The American Stroke Association 28th International Stroke Conference, 2003; Phoenix, AZ. Available from: http://www.strokeconference.org/sc_includes/ pdfs/CTP34.pdf.
7. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of ≥80 versus < 80 years of age-a systematic review across cohort studies. Age Ageing 2006; 35: 572-80.
8. Parnettti L, Silvestrelli G, Lanari A et al. Efficacy of thrombolytic (rt-PA) therapy in old stroke, patients: The Perugia Stroke Unit Experience. Clin Exp Hypertens 2006; 28: 397-404.
9. Sylaja PN, Cote R, Buchan AM et al. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatr 2006; 77: 826-9.
10. van Oostenbrugge RJ, Hupperts RM, Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: Experience from a single Dutch centre. J Neurol Neurosurg Psychiatr 2006; 77: 375-7.
11. Chen CI, Iguchi Y, Grotta JC et al. Intravenous TPA for very old stroke patients. Eur Neurol 2005; 54: 140-4.
12. Engelter ST, Reichhart M, Sekoranja L et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005; 65:1795-8.
13. Berrouschot J, Rother J, Glahn J et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥ 80 years) stroke patients. Stroke 2005; 36: 2421-5.
14. Mouradian MS, Senthilselvan A, Jickling G et al. Intravenous rt-PA for acute stroke: Comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatr 2005; 76: 1234-7.
15. Tanne D, Gorman MJ, Bates VE et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke 2000; 31: 370-5.
16. Vatankhah B, Dittmar MS, Fehm NP et al. Thrombolysis for stroke in the elderly. J Thromb Thrombolysis 2005; 20: 5-10.
17. Simon JE, Sandler DL, Pexman JH et al. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience. Age Ageing 2004; 33: 143-9.
18. Hill IMD, Buchan MA, Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for stroke effectiveness study. Can Med Assoc J 2005; 172: 1307-12.
19. Kammersgaard LP, Jorgensen HS, Reith J et al. Short-and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing 2004; 33: 149-54.
20. Di Carlo A, Lamassa M, Pracucci G et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group. Stroke 1999; 30: 2313-9.
21. Mayo NE, Neville D, Kirkland S et al. Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 1996; 27: 1215-20.
22. Adams HP Jr, Davis PH, Leira EC et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53:126-31.
23. Subgroup Analysis of die NINDS t-PA Stroke Trial. Generalized efficacy of t-PA for acute stroke. Stroke 1997; 28: 2119-23.